KARL STORZ and Well Lead Medical Announce Exclusive Agreement for Distribution of ClearPetra Stone-Removal System in the U.S.
May 02 2024 - 2:14PM
Business Wire
KARL STORZ United States announces an exclusive agreement with
Well Lead Medical to offer the ClearPetra suction-evacuation
ureteral access sheath in conjunction with KARL STORZ endoscopic
visualization devices for comprehensive urinary stone
management.
The ClearPetra ureteral access sheath uses negative-pressure
aspiration, enabling efficient and effective continuous-flow
lithotripsy for stone removal.1 Now with a flexible tip, the sheath
can be steered into the calyces within the kidney to remove renal
stones.
ClearPetra signifies a breakthrough in urolithiasis treatment.
This strategic collaboration aims to transform the landscape of
endourology, enhancing patient care and surgical outcomes.
“Our strategic collaboration with Well Lead Medical on
ClearPetra represents a major step forward in stone management. We
are excited to provide this clinically differentiated technology,
which is complementary to the range of solutions KARL STORZ offers
urologists,” said Michael Hendershot, Vice President, Urology and
Gynecology, Sales and Marketing at KARL STORZ United States.
“The collaboration between Well Lead Medical and KARL STORZ
represents a significant milestone in our commitment to advancing
endourology. The ClearPetra innovative technology, coupled with
KARL STORZ's expertise in endoscopic solutions, will empower
urologists to achieve superior surgical outcomes," said Duan
Songfeng, Vice General Manager, International Sales &
Marketing, Research Institute at Well Lead Medical.
Join KARL STORZ at the American Urological Association in San
Antonio May 3–5.
Visit KARL STORZ at the AUA conference from May 3 to 5 to get
hands-on experience with ClearPetra and learn how it can impact the
treatment of urinary stones.
During the show, KARL STORZ will be sponsoring a Tech Talk on
May 4, 10:00–10:25 a.m., at Booth #1733. Sri Sivalingam, MD,
MSc, FRCSC, Cleveland Clinic, will discuss his experience using
ClearPetra and its effect on clinical practice. The talk will focus
on the practical applications of stone aspiration with ClearPetra
for PCNL and flexible ureteroscopy procedures.
About KARL STORZ
KARL STORZ is an innovative leader in endoscopic technology and
surgical imaging solutions across virtually all surgical
specialties. The company offers a comprehensive range of urology
solutions, including numerous approaches to stone management—e.g.,
flexible ureteroscopy, minimally invasive PCNL, and thulium fiber
laser. With subsidiaries around the world, KARL STORZ is a
family-owned company based in Germany that designs, engineers,
manufactures, and markets all its products with an emphasis on
visionary design, precision craftsmanship, and clinical
effectiveness. For more information, visit www.karlstorz.com.
References
1 Tuoheti KB et al. A novel double-sheath negative-pressure
versus conventional minimally invasive percutaneous nephrolithotomy
for large kidney stone. Nature: Sci Rep 13. 2023. doi:
10.1038/s41598-023-50237-7
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240502515259/en/
MEDIA CONTACT: Susan Mancia Director, Integrated Marketing
Communications KARL STORZ United States 562-841-1515
susan.mancia@karlstorz.com